Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

University of Patras

Status: Completed

Conditions: SARS-CoV2 Infection; Vaccine Reaction

Treatments: Biological: Approved vaccines against Sars-Cov2

Study type: Observational

Funder types: Other

Identifiers

NCT04954651

99-25/2/2021

Details and patient eligibility

About

Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).

Enrollment: 1,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who voluntarily receive COVID-19 vaccination

Exclusion criteria

• Patients who do not complete their vaccination
• Patients who do not provide info on their health status

Trial design

1,000 participants in 1 patient group

VAC

Description:

Vaccinated subject against Sars-Cov2

Treatment:

Biological: Approved vaccines against Sars-Cov2